Global Pipeline Market Access Director – Pre-Launch Strategy

AbbVie Inc.; Florham Park (NJ); On-site; USD 250,000 - 350,000; Full time

Job summary

AbbVie Inc. is seeking a Senior Director of Pipeline Market Access Strategy to lead end-to-end access strategies for pipeline assets across the business unit.

You will shape pricing, evidence generation, and regulatory engagement to optimize global launch readiness and payer acceptance. You will steer cross-functional teams in the US and internationally, aligning HEOR, R&D, Regulatory, and Government Affairs to deliver integrated access plans that support AbbVie’s portfolio value and patient

Qualifications

• Advanced degree required (MBA/MPH/PhD/PharmD) or equivalent.
• Bachelor’s degree in science, business, or public health is required.
• Formal training or demonstrated expertise in HTA, HEOR, or pharmaceutical development preferred.

Responsibilities

• Owns end-to-end pipeline market access strategy across pre-launch and development assets.
• Leads US and International strategy alignment and governance reviews with senior leadership.
• Partners with R&D, Regulatory, HEOR, and Government Affairs to embed market access considerations into development plans.

Skills

Strategic vision

Leadership

Global HTA & Payer Expertise

Clinical development partnership

Evidence generation strategy

US/International strategy alignment

Executive communication

Portfolio prioritization

Education

Advanced degree (MBA/MPH/PhD/PharmD)

Bachelor’s degree in science, business, or public health

HTA/HEOR training or expertise

Job description

AbbVie Inc. is seeking a Senior Director of Pipeline Market Access Strategy to lead end-to-end access strategies for pipeline assets across the business unit.

You will shape pricing, evidence generation, and regulatory engagement to optimize global launch readiness and payer acceptance. You will steer cross-functional teams in the US and internationally, aligning HEOR, R&D, Regulatory, and Government Affairs to deliver integrated access plans that support AbbVie’s portfolio value and patient